Epigenetic unsilencing reverses renal fibrosis

Journal of the American Society of Nephrology

Volumn 25, Issue 5, 2014, Pages 865-866

  Higgins, Debra F ^a   Murphy, Madeline ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; ANTIFIBROTIC AGENT; DNA METHYLTRANSFERASE; ENZYME; OSTEOGENIC PROTEIN 1; REGULATOR PROTEIN; TET1 ENZYME; TET2 ENZYME; TET3 ENZYME; UNCLASSIFIED DRUG; BMP7 PROTEIN, MOUSE; DNA BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; ONCOPROTEIN; RASAL1 PROTEIN, MOUSE; TET3 PROTEIN, MOUSE;

CELL DIFFERENTIATION; CHRONIC KIDNEY DISEASE; CPG ISLAND; DNA METHYLATION; EDITORIAL; EPIGENETICS; FIBROGENESIS; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GENOME IMPRINTING; KIDNEY DEVELOPMENT; KIDNEY FIBROSIS; MESENCHYME CELL; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RASAL1 GENE; STREPTOZOTOCIN-INDUCED DIABETIC NEUROPATHY; TRANSCRIPTION REGULATION; URETER OBSTRUCTION; X CHROMOSOME INACTIVATION; ANIMAL; DRUG EFFECT; GENETICS; NEPHROSCLEROSIS; NOTE; PHYSIOLOGY;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; DNA METHYLATION; DNA-BINDING PROTEINS; GENE SILENCING; GTPASE-ACTIVATING PROTEINS; NEPHROSCLEROSIS; PROTO-ONCOGENE PROTEINS;

EID: 84906539167     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014010006     Document Type: Editorial

References (13)

1. Zhang C, Liang Y, Lei L, Zhu G, Chen X, Jin T, Wu Q: Hypermethylations of RASAL1 and KLOTHO is associated with renal dysfunction in a Chinese population environmentally exposed to cadmium. Toxicol Appl Pharmacol 271: 78-85, 2013
2. Ko YA, Mohtat D, Suzuki M, Park AS, Izquierdo MC, Han SY, Kang HM, Si H, Hostetter T, Pullman JM, Fazzari M, Verma A, Zheng D, Greally JM, Susztak K: Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol 14: R108, 2013
3. Bechtel W, McGoohan S, Zeisberg EM, Müller GA, Kalbacher H, Salant DJ, Müller CA, Kalluri R, Zeisberg M: Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 16: 544-550, 2010
4. Woroniecki R, Gaikwad AB, Susztak K: Fetal environment, epigenetics, and pediatric renal disease. Pediatr Nephrol 26: 705-711, 2011
5. Kohli RM, Zhang Y: TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502: 472-479, 2013
6. Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, Hore TA, Marques CJ, Andrews S, Reik W: Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473: 398-402, 2011
7. Tampe B, Tampe D, Müller C, Sugimoto H, LeBleu V, Xu X, Müller G, Zeisberg EM, Kalluri R, Zeisberg M: Tet3-mediated hydroxymethylation of epigetically silenced genes contributes to BMP7-induced reversal of kidney fibrosis. J Am Soc Nephrol 25: 905-912, 2014
8. Wu SC, Zhang Y: Active DNA demethylation: Many roads lead to Rome. Nat Rev Mol Cell Biol 11: 607-620, 2010
9. Cadet J, Wagner JR: TET enzymatic oxidation of 5-methylcytosine, 5-hydroxymethylcytosine and 5-formylcytosine [published online ahead of print September 14,2013].MutatRes doi:10.1016/j.mrgentox.2013.09.001
10. Piccolo FM, Fisher AG: Getting rid of DNA methylation. Trends Cell Biol: 2013
11. Dudley AT, Lyons KM, Robertson EJ: A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9: 2795-2807, 1995
12. Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G: BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9: 2808-2820, 1995
13. Vukicevic S, Kopp JB, Luyten FP, Sampath TK: Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). Proc Natl Acad Sci U S A 93: 9021-9026, 1996